BIOPIA is a non-profit collaborative effort of European labs with expertise in biotherapeutical immunogenicity and a spin-off from ABIRISK. The aim is to raise awareness about immunogenicity by:
Providing tests for anti-drug antibodies (ADA) and drug levels and thereby help clinicians assess treatment responses in their patients
Connect European labs and hospitals, with the goal of a having a more efficient implementation of drug levels and ADA in clinical routine
For information about biopharmaceuticals, immunogenicity, and why clinical assessment needs to include tests for ADAs.
Find the lab nearest you that assesses drug and ADA levels
Find your biologic of interest from a list of commercially available drugs